News

Filter

1 to 9 of 97218 results

AstraZeneca’s Lynparza gains FDA approval

20-12-2014

The US Food and Drug Administration has granted accelerated approved for Anglo-Swedish drug major AstraZeneca’s…

AstraZenecaLynparzaOncologyPharmaceuticalRegulationUSA

FDA approves fourth hepatitis C drug, AbbVie’s Viekira Pak

20-12-2014

The US Food and Drug Administration on Friday confirmed the much anticipated approval of US pharma company…

AbbVieAnti-viralsPharmaceuticalRegulationUSAViekira Pak

FDA approves new antibacterial drug Zerbaxa

20-12-2014

The US Food and Drug Administration has approved Cubist Pharmaceuticals’Zerbaxa (ceftolozane/tazobactam)…

Antibiotics and Infectious diseasesCubist PharmaceuticalsMerck & CoPharmaceuticalRegulationUSAZerbaxa

Bina Technologies is acquired by Roche

20-12-2014

Swiss pharma giant Roche has acquired Bina Technologies, a privately held company based in Redwood City,…

Bina TechnologiesBiotechnologyMergers & AcquisitionsRoche

RXi and Hapten enter into licensing agreement for Samcyprone

RXi and Hapten enter into licensing agreement for Samcyprone

19-12-2014

RNA technology specialist RXi Pharmaceuticals Corp has entered into a global licensing agreement with…

BiotechnologyDermatologicalsLicensingNeurologicalRXi Pharmaceuticals

Cuba a huge opportunity for life sciences, says Abivax

Cuba a huge opportunity for life sciences, says Abivax

19-12-2014

Paris-based antiviral specialist Abivax has spoken in praise of the decision between the USA and Cuba…

ABIVAXABIVAXCubaPharmaceuticalUnited States

Takeda appoints Andy Plump as corporate officer and chief medical and scientific officer designate

Takeda appoints Andy Plump as corporate officer and chief medical and scientific officer designate

19-12-2014

Japan’s largest drugmaker Takeda Pharmaceutical has appointed Andy Plump as corporate officer and chief…

Andy PlumpBoardroomPharmaceuticalTakeda PharmaceuticalTakeda Pharmaceutical Company

Seven new drugs recommended by EMA/CHMP in December 2014, 82 overall in 2014

Seven new drugs recommended by EMA/CHMP in December 2014, 82 overall in 2014

19-12-2014

Seven new drugs have been recommended for marketing authorization at the December 2014 meeting of the…

ActavisAntibiotics and Infectious diseasesCardio-vascularChiesi FarmaceuticiClopidogrelDurata TherapeuticsEuropeGenzymeHoloclarMetabolicsMysimbaNephrology and HepatologyNewron PharmaOrexigen TherapeuticsPharmaceuticalQuinsairRegulationTasermityTeva Pharmaceutcal IndustriesXadagoXydalbaZambon

1 to 9 of 97218 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top